tiprankstipranks
Trending News
More News >
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market

Laboratorios Farmaceuticos Rovi (ROVI) Income Statement

Compare
33 Followers

Laboratorios Farmaceuticos Rovi Income Statement

Last quarter (Q3 2025), Laboratorios Farmaceuticos Rovi's total revenue was €210.47M, a decrease of -10.54% from the same quarter last year. In Q3, Laboratorios Farmaceuticos Rovi's net income was €58.03M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 763.75M€ 829.51M€ 817.70M€ 648.68M€ 419.96M
Gross Profit
€ 478.35M€ 483.34M€ 519.61M€ 384.82M€ 241.31M
Operating Expenses
€ 298.80M€ 263.09M€ 263.76M€ 203.34M€ 163.88M
Depreciation and Amortization
€ 28.02M€ 24.33M€ 22.87M€ 21.36M€ 19.59M
EBITDA
€ 207.69M€ 245.81M€ 281.49M€ 204.72M€ 93.28M
Operating Income
€ 179.54M€ 220.25M€ 255.85M€ 181.57M€ 74.68M
Other Income/Expenses
€ -1.85M€ 154.00K€ 1.92M€ 1.24M€ -2.07M
Pretax Income
€ 177.69M€ 220.41M€ 257.97M€ 182.63M€ 72.58M
Net Income
€ 136.88M€ 170.34M€ 199.67M€ 153.08M€ 61.06M
Per Share Metrics
Basic EPS
€ 2.67€ 3.29€ 3.73€ 2.76€ 1.10
Diluted EPS
€ 2.67€ 3.29€ 3.73€ 2.76€ 1.10
Weighted Average Shares Outstanding
51.27M 51.82M 53.47M 55.40M 55.39M
Weighted Average Shares Outstanding (Diluted)
51.27M 51.82M 53.47M 55.40M 55.39M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History